DVA Logo

DaVita Inc (DVA) Stock Forecast & Price Prediction

Live DVA Stock Price & Analysis

Home โ€บ Stocks โ€บ United States | NYSE | Healthcare | Medical Care Facilities

$173.52

-0.06 (-0.03%)

12 Month Price Forecast For DVA

$173.52
Current Price
$14.15B
Market Cap
9 Ratings
Buy 1
Hold 7
Sell 1
Wall St Analyst Ratings

Distance to DVA Price Forecasts

+7.2%
To High Target of $186.00
-5.5%
To Median Target of $164.00
-22.8%
To Low Target of $134.00

DVA Price Momentum

-2.2%
1 Week Change
+13.1%
1 Month Change
+57.9%
1 Year Change
+16.0%
Year-to-Date Change
-3.4%
From 52W High of $179.60
+59.5%
From 52W Low of $108.76

๐Ÿค” Considering DaVita (DVA)?

Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.

Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.

Data last updated: February 11, 2025 6:42 AM UTC

DVA Analyst Ratings & Price Targets

Based on our analysis of 10 Wall Street analysts, DVA has a neutral consensus with a median price target of $164.00 (ranging from $134.00 to $186.00). The overall analyst rating is Buy (6.2/10). Currently trading at $173.52, the median forecast implies a -5.5% downside. This outlook is supported by 1 Buy, 7 Hold, and 1 Sell ratings.

Conversely, the most conservative target is provided by Andrew Mok at UBS, suggesting a 22.8% downside.

Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.

DVA Analyst Consensus

1
Buy
7
Hold
1
Sell

DVA Price Target Range

Low
$134.00
Average
$164.00
High
$186.00
Current: $173.52

Latest DVA Stock Forecasts by Analyst

These are the latest 20 analyst ratings and price targets for DVA.

Date Firm Analyst Rating Change Price Target
Oct 31, 2024 Barclays Andrew Mok Equal-Weight Maintains $164.00
Oct 7, 2024 Truist Securities David Macdonald Hold Maintains $175.00
Aug 20, 2024 Truist Securities David Macdonald Hold Maintains $165.00
Aug 8, 2024 UBS Andrew Mok Buy Maintains $175.00
Aug 7, 2024 B of A Securities Kevin Fischbeck Underperform Maintains $145.00
Jul 24, 2024 TD Cowen Gary Taylor Hold Maintains $150.00
May 15, 2024 Truist Securities David Macdonald Hold Maintains $150.00
May 6, 2024 Barclays Andrew Mok Equal-Weight Maintains $150.00
Mar 6, 2024 Barclays Sarah James Equal-Weight Initiates $133.00
Feb 20, 2024 Truist Securities David Macdonald Hold Maintains $135.00
Feb 15, 2024 UBS Andrew Mok Buy Maintains $145.00
Feb 14, 2024 Truist Securities David Macdonald Hold Maintains $130.00
Feb 14, 2024 UBS Andrew Mok Buy Maintains $134.00
Nov 17, 2023 UBS Andrew Mok Buy Maintains $113.00
Oct 11, 2023 Truist Securities David Macdonald Hold Maintains $104.00
Aug 7, 2023 UBS Andrew Mok Buy Upgrade $142.00
Jul 13, 2023 Truist Securities David Macdonald Hold Maintains $115.00
May 15, 2023 Bernstein Lisa Bedell Clive Market Perform Maintains $100.00
May 9, 2023 B of A Securities Kevin Fischbeck Underperform Maintains $96.00
May 9, 2023 Truist Securities David Macdonald Hold Maintains $100.00

Stocks Similar to DaVita Inc

The following stocks are similar to DaVita based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.

DaVita Inc (DVA) Financial Data

DaVita Inc has a market capitalization of $14.15B with a P/E ratio of 18.6x. The company generates $12.67B in trailing twelve-month revenue with a 6.5% profit margin.

Revenue growth is +4.6% quarter-over-quarter, while maintaining an operating margin of +16.3% and return on equity of +44.9%.

Valuation Metrics

Market Cap $14.15B
Enterprise Value $27.17B
P/E Ratio 18.6x
PEG Ratio 15.3x
Price/Sales 1.1x

Growth & Margins

Revenue Growth (YoY) +4.6%
Gross Margin +34.1%
Operating Margin +16.3%
Net Margin +6.5%
EPS Growth -13.0%

Financial Health

Cash/Price Ratio +7.7%
Current Ratio 1.4x
Debt/Equity 549.6x
ROE +44.9%
ROA +6.9%

๐Ÿ”ฅ Want More High-Potential Stock Ideas?

Join 5,000+ investors getting our research on stocks with massive upside potential.

DaVita Inc logo

DaVita Inc (DVA) Company Overview

About DaVita Inc

What They Do

Provides kidney dialysis services to patients.

Business Model

The company operates kidney dialysis centers and offers a variety of services, including outpatient and home-based hemodialysis, as well as lab services. It generates revenue through patient treatments, laboratory services, and management services for outpatient centers, alongside integrated care arrangements and clinical research programs.

Additional Information

Incorporated in 1994 and headquartered in Denver, Colorado, DaVita Inc. was previously known as DaVita HealthCare Partners Inc. The company has expanded its services to include acute inpatient dialysis and transplant software solutions, enhancing its comprehensive kidney care offerings.

Company Information

Sector

Healthcare

Industry

Medical Care Facilities

Employees

70,000

CEO

Mr. Javier J. Rodriguez

Country

United States

IPO Year

1995

DaVita Inc (DVA) Latest News & Analysis

DVA stock latest news image
Quick Summary

DaVita HealthCare (DVA) closed at $177.35, reflecting a 0.16% increase from the prior trading day.

Why It Matters

DaVita HealthCare's slight price increase indicates stability and may reflect positive market sentiment, influencing investor confidence and future trading decisions.

Source: Zacks Investment Research
Market Sentiment: Neutral
DVA stock latest news image
Quick Summary

Warren Buffett, renowned investor and leader of Berkshire Hathaway, is a key figure in investment strategy, with many investors attempting to emulate his approach.

Why It Matters

Warren Buffett's investing strategy influences market trends and investor behavior, making Berkshire Hathaway's holdings a key indicator for potential investment opportunities.

Source: The Motley Fool
Market Sentiment: Positive
DVA stock latest news image
Quick Summary

DaVita Inc. (NYSE: DVA) will hold its fourth quarter results conference call on February 13, 2025, at 5:00 p.m. Eastern Time.

Why It Matters

DaVita's upcoming quarterly call will provide insights into its financial performance, which can influence stock price and investor sentiment. Key metrics discussed may affect investment decisions.

Source: PRNewsWire
Market Sentiment: Neutral
DVA stock latest news image
Quick Summary

Investors are focusing on bullish stocks, including ENS, DVA, REVG, and PAA, which are experiencing price strength and expected to maintain momentum.

Why It Matters

Bullish momentum in stocks like ENS, DVA, REVG, and PAA indicates potential for further price appreciation, attracting investor interest and driving demand.

Source: Zacks Investment Research
Market Sentiment: Positive
DVA stock latest news image
Quick Summary

No specific details were provided about the events that occurred over the weekend. Investors should seek further information for context and implications.

Why It Matters

Vague news can indicate potential market volatility or shifts in sentiment, prompting investors to stay alert to new developments that could impact asset valuations.

Source: Zacks Investment Research
Market Sentiment: Positive
DVA stock latest news image
Quick Summary

DaVita HealthCare (DVA) has been upgraded to a Zacks Rank #1 (Strong Buy), indicating positive earnings outlook and potential for short-term stock price increase.

Why It Matters

DaVita HealthCare's upgrade to a Zacks Rank #1 signals strong earnings potential, likely boosting investor confidence and driving the stock price upward.

Source: Zacks Investment Research
Market Sentiment: Positive

Frequently Asked Questions About DVA Stock

What is DaVita Inc's (DVA) stock forecast for 2025?

Based on our analysis of 10 Wall Street analysts, DaVita Inc (DVA) has a median price target of $164.00. The highest price target is $186.00 and the lowest is $134.00.

Is DVA stock a good investment in 2025?

According to current analyst ratings, DVA has 1 Buy ratings, 7 Hold ratings, and 1 Sell ratings. The stock is currently trading at $173.52. Always conduct your own research and consider your investment goals before making investment decisions.

What is the price prediction for DVA stock?

Wall Street analysts predict DVA stock could reach $164.00 in the next 12 months. This represents a -5.5% decrease from the current price of $173.52. Please note that this is a projection by Wall Street analysts and not a guarantee.

What is DaVita Inc's business model?

The company operates kidney dialysis centers and offers a variety of services, including outpatient and home-based hemodialysis, as well as lab services. It generates revenue through patient treatments, laboratory services, and management services for outpatient centers, alongside integrated care arrangements and clinical research programs.

What is the highest forecasted price for DVA DaVita Inc?

The highest price target for DVA is $186.00 from at , which represents a 7.2% increase from the current price of $173.52.

What is the lowest forecasted price for DVA DaVita Inc?

The lowest price target for DVA is $134.00 from Andrew Mok at UBS, which represents a -22.8% decrease from the current price of $173.52.

What is the overall DVA consensus from analysts for DaVita Inc?

The overall analyst consensus for DVA is neutral. Out of 10 Wall Street analysts, 1 rate it as Buy, 7 as Hold, and 1 as Sell, with a median price target of $164.00.

How accurate are DVA stock price projections?

Stock price projections, including those for DaVita Inc, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.